LOTTE BIOLOGICS was honored to participate in the 'ISPE Singapore' conference, held in Singapore from August 23rd to 25th. As a non-profit organization, 'ISPE' brought together experts from the pharmaceutical and biotech industries to set the standards for Good Manufacturing Practices (GMP). 'ISPE Singapore' stands as the largest event in the local pharmaceutical and biotech calendar. 

During the conference, Richard Lee, the CEO of LOTTE BIOLOGICS, delivered a notable keynote speech. He highlighted how the aging population in Asia has driven the rapid expansion of automation and advanced therapies. Richard Lee also utilized this platform to promote LOTTE BIOLOGICS' CDMO business, effectively intertwining industry and business insights.